Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dabigatran reduces thrombin-induced neuroinflammation and AD markers in vitro: Therapeutic relevance for Alzheimer's disease

Cerebral Circulation - Cognition and Behavior(2021)10.1016/j.cccb.2021.100014Source: DataRank Database

Dabigatran reduces thrombin-induced neuroinflammation and AD markers in vitro: Therapeutic relevance for Alzheimer's disease is a research paper published in Cerebral Circulation - Cognition and Behavior (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (22)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Haripriya Vittal Rao,Abhik Sen ORCID,Paula Grammas ORCID,Syed Waseem Bihaqi ORCID

Live enrichment

PubMed:36324711 PMC:PMC9616330

National Institutes of Health

Grant: R21NS110628

National Institute of General Medical Sciences

Grant: P20GM103430

National Institutes of Health

Grant: 2P20GM103430-14

Bioinformatics Core

National Institutes of Health

Grant: 1R21NS110628-01

Thrombin: A therapeutic target for cerebral amyloid angiopathy

Cure Alzheimer's Fund

goldLicense: cc-by-nc-nd

publisherhttps://www.sciencedirect.com/science/article/pii/S2666245021000118/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2666245021000118?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666245021000118?httpAccept=text/plain

repositoryhttps://jdc.jefferson.edu/pacbfp/354

repositoryhttps://doaj.org/article/c2c83101daef4c86bf2e9b6a1b98fcd5

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

ThrombinAlzheimer's diseaseTauSH-SY5YNfκbDabigatranAβ610Specialties of internal medicineNeurosciences. Biological psychiatry. NeuropsychiatryArticleMedical Cell BiologyMedical PathologyNeurologyRC581-951616Medicine and Health SciencesMedical AnatomyRC321-571

Sustainable Development Goals

SDG 3: 3. Good health

Dabigatran reduces thrombin-induced neuroinflammation and AD markers in vitro: Therapeutic relevance for Alzheimer's disease

FAIR Checklist

Authors (4)

Funding (5 grants)

Open Access

Topics

Annotations (Europe PMC)